Switzerland
Cerbios-Pharma SA, founded in 1976 and headquartered in Switzerland, is a leading player in the biotechnology, manufacturing, and pharmaceutical industries. The company's slogan "Fostering Value through Innovation" reflects its commitment to driving innovation in the pharmaceutical sector.
With over 45 years of experience, Cerbios specializes in the manufacturing of Generic APIs & HPAPIs, finished formulations based on its proprietary probiotic strain, and exclusive CDMO services for HPAPIs, ADCs, and recombinant proteins.
The company's portfolio includes a diverse range of drug substances, including reduced folates and Vitamin D derivatives, manufactured exclusively for its customers. Cerbios also has a long-standing experience in the probiotics field, producing finished pharmaceutical drugs based on its proprietary strain for the treatment of diarrhea and dysbiosis.
Cerbios offers CDMO services, making it an ideal partner for the clinical to commercial supply of API, HPAPIs, payloads, ADCs, proteins, and antibodies, encompassing process & analytical development, scale-up, clinical supply, industrial validation, commercial supply, and full CMC regulatory support.
The company's ADC dedicated division, Proveo (TM), leverages its expertise in payloads and recombinant proteins to offer an end-to-end solution for Antibody Drug Conjugates (ADCs).
Besides pharmaceutical products, Cerbios also offers a range of products for animal feed or veterinary applications, including probiotic feed additives.
With its diverse and innovative offerings, Cerbios-Pharma SA has positioned itself as a key player in the pharmaceutical industry, with a strong focus on driving value through cutting-edge innovations and high-quality manufacturing.
